Literature DB >> 17180318

Effects of corticoliberin CRF(4-6) fragment on pain sensitivity in rats.

E Yu Makarenko1, L A Andreeva, A A Mart'yanov.   

Abstract

The effects of the tripeptide fragment corticoliberin CRF(4-6) (Pro-Pro-Ile) on pain sensitivity were studied in rats using the hotplate method. CRF(4-6) given centrally (6, 30, and 150 nmol/rat) had dose-dependent antinociceptive actions: the latent period of the paw-licking response increased by 7.4 +/- 1.4, 10.1 +/- 1.5, and 16.7 +/- 4.2 sec from the control level of 10.2 +/- 0.9 sec. The durations of the effect were 30 min for CRF(4-6) at a dose of 6 nmol and 60 min for doses of 30 and 150 nmol of tripeptide. Administration of the corticoliberin antagonist alpha h CRF(9-41) (centrally, 6.5 nmol) 60 min before tripeptide completely blocked the antinociceptive effects of CRF(4-6) (6 nmol). Thus, corticoliberin receptors are involved in mediating the antinociceptive influence of CRF(4-6). It can be suggested that the tripeptide either directly interacts with corticoliberin receptors or modulates the activity of CRFergic neurons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17180318     DOI: 10.1007/s11055-007-0148-7

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  18 in total

1.  Different direct pathways of locus coeruleus to medial prefrontal cortex and centrolateral thalamic nucleus: electrical stimulation effects on the evoked responses to nociceptive peripheral stimulation.

Authors: 
Journal:  Eur J Pain       Date:  1998-03       Impact factor: 3.931

2.  [Effect of the corticoliberin fragment CRF(4-6) on blood pressure and heart rate in rats].

Authors:  E Iu Makarenko; L A Andreeva; A S Borovik; A A Mart'ianov
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2005-01

3.  A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.

Authors:  P J Trainer; M Faria; J Newell-Price; P Browne; P Kopelman; D H Coy; G M Besser; A B Grossman
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

4.  Stress-produced analgesia and morphine-produced analgesia: lack of cross-tolerance.

Authors:  R J Bodnar; D D Kelly; S S Steiner; M Glusman
Journal:  Pharmacol Biochem Behav       Date:  1978-06       Impact factor: 3.533

5.  Corticotropin-releasing factor (CRF) produces analgesia in humans and rats.

Authors:  K M Hargreaves; G P Mueller; R Dubner; D Goldstein; R A Dionne
Journal:  Brain Res       Date:  1987-09-29       Impact factor: 3.252

6.  Convulsant peptides related to corticotropin-releasing factor (CRF).

Authors:  M Nomizu; M Miyamoto
Journal:  Brain Res       Date:  1989-12-29       Impact factor: 3.252

Review 7.  Deep brain and motor cortex stimulation for post-stroke movement disorders and post-stroke pain.

Authors:  Y Katayama; T Yamamoto; K Kobayashi; H Oshima; C Fukaya
Journal:  Acta Neurochir Suppl       Date:  2003

8.  [Effect of a corticoliberin (CRF4-6) on the rat heart rate and behavior].

Authors:  E Iu Makarenko; L A Andreeva; A S Borovik; A A Mart'ianov
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2003-08

9.  Immobilisation stress-induced antinociception in rats: possible role of serotonin and prostaglandins.

Authors:  S K Bhattacharya; P R Keshary; A K Sanyal
Journal:  Eur J Pharmacol       Date:  1978-07-01       Impact factor: 4.432

10.  Corticotropin releasing hormone, interleukin-1 alpha, and tumor necrosis factor-alpha share characteristics of stress mediators.

Authors:  M Bianchi; P Sacerdote; L Locatelli; P Mantegazza; A E Panerai
Journal:  Brain Res       Date:  1991-04-12       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.